$TRVI Trevi Therapeutics, Inc. Insider Trading Week 19/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Trevi Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Trevi Therapeutics, Inc. in week 19/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2019 | TRVI | Trevi Therapeutics ... | TPG Group Holdings (SBS) Advis ... | Option Exercise | J | 0.00 | 1 | 0 | 1 | ||
| May 13 2019 | TRVI | Trevi Therapeutics ... | TPG Group Holdings (SBS) Advis ... | Option Exercise | J | 0.00 | 1 | 0 | 1 | ||
| May 13 2019 | TRVI | Trevi Therapeutics ... | TPG Group Holdings (SBS) Advis ... | Option Exercise | C | 0.00 | 8,243,948 | 0 | 0 | ||
| May 13 2019 | TRVI | Trevi Therapeutics ... | TPG Group Holdings (SBS) Advis ... | Option Exercise | C | 0.00 | 21,739,130 | 0 | 0 | ||
| May 13 2019 | TRVI | Trevi Therapeutics ... | TPG Group Holdings (SBS) Advis ... | Option Exercise | C | 0.00 | 13,164,257 | 0 | 0 | ||
| May 13 2019 | TRVI | Trevi Therapeutics ... | TPG Group Holdings (SBS) Advis ... | Sell | J | 0.00 | 48,681 | 0 | 6,524,319 | 6.6 M to 6.5 M (-0.74 %) | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | TPG Group Holdings (SBS) Advis ... | Buy | P | 10.00 | 800,000 | 8,000,000 | 6,573,000 | 5.8 M to 6.6 M (+13.86 %) | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | TPG Group Holdings (SBS) Advis ... | Buy | C | 0.00 | 5,773,000 | 0 | 5,773,000 | 0 to 5.8 M | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Walker Paul Edward | 10% Owner | Option Exercise | C | 0.00 | 17,099,315 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Walker Paul Edward | 10% Owner | Buy | P | 10.00 | 1,500,000 | 15,000,000 | 4,438,562 | 2.9 M to 4.4 M (+51.05 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Walker Paul Edward | 10% Owner | Buy | P | 10.00 | 1,000,000 | 10,000,000 | 2,938,562 | 1.9 M to 2.9 M (+51.58 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Walker Paul Edward | 10% Owner | Buy | C | 0.00 | 1,938,562 | 0 | 1,938,562 | 0 to 1.9 M |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Sonsini Peter W. | 10% Owner | Option Exercise | C | 0.00 | 17,099,315 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Sonsini Peter W. | 10% Owner | Buy | P | 10.00 | 1,500,000 | 15,000,000 | 4,438,562 | 2.9 M to 4.4 M (+51.05 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Sonsini Peter W. | 10% Owner | Buy | P | 10.00 | 1,000,000 | 10,000,000 | 2,938,562 | 1.9 M to 2.9 M (+51.58 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Sonsini Peter W. | 10% Owner | Buy | C | 0.00 | 1,938,562 | 0 | 1,938,562 | 0 to 1.9 M |
| May 13 2019 | TRVI | Trevi Therapeutics ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 17,099,315 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | SANDELL SCOTT D | 10% Owner | Buy | P | 10.00 | 1,500,000 | 15,000,000 | 4,438,562 | 2.9 M to 4.4 M (+51.05 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | SANDELL SCOTT D | 10% Owner | Buy | P | 10.00 | 1,000,000 | 10,000,000 | 2,938,562 | 1.9 M to 2.9 M (+51.58 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 1,938,562 | 0 | 1,938,562 | 0 to 1.9 M |
| May 13 2019 | TRVI | Trevi Therapeutics ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 17,099,315 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | MOTT DAVID M | 10% Owner | Buy | P | 10.00 | 1,500,000 | 15,000,000 | 4,438,562 | 2.9 M to 4.4 M (+51.05 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | MOTT DAVID M | 10% Owner | Buy | P | 10.00 | 1,000,000 | 10,000,000 | 2,938,562 | 1.9 M to 2.9 M (+51.58 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 1,938,562 | 0 | 1,938,562 | 0 to 1.9 M |
| May 13 2019 | TRVI | Trevi Therapeutics ... | MAKOWER JOSHUA | 10% Owner | Option Exercise | C | 0.00 | 17,099,315 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | MAKOWER JOSHUA | 10% Owner | Buy | P | 10.00 | 1,500,000 | 15,000,000 | 4,438,562 | 2.9 M to 4.4 M (+51.05 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | MAKOWER JOSHUA | 10% Owner | Buy | P | 10.00 | 1,000,000 | 10,000,000 | 2,938,562 | 1.9 M to 2.9 M (+51.58 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | MAKOWER JOSHUA | 10% Owner | Buy | C | 0.00 | 1,938,562 | 0 | 1,938,562 | 0 to 1.9 M |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Makhzoumi Mohamad | 10% Owner | Option Exercise | C | 0.00 | 17,099,315 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Makhzoumi Mohamad | 10% Owner | Buy | P | 10.00 | 1,500,000 | 15,000,000 | 4,438,562 | 2.9 M to 4.4 M (+51.05 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Makhzoumi Mohamad | 10% Owner | Buy | P | 10.00 | 1,000,000 | 10,000,000 | 2,938,562 | 1.9 M to 2.9 M (+51.58 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Makhzoumi Mohamad | 10% Owner | Buy | C | 0.00 | 1,938,562 | 0 | 1,938,562 | 0 to 1.9 M |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Florence Anthony A. Jr. | 10% Owner | Option Exercise | C | 0.00 | 17,099,315 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Florence Anthony A. Jr. | 10% Owner | Buy | P | 10.00 | 1,500,000 | 15,000,000 | 4,438,562 | 2.9 M to 4.4 M (+51.05 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Florence Anthony A. Jr. | 10% Owner | Buy | P | 10.00 | 1,000,000 | 10,000,000 | 2,938,562 | 1.9 M to 2.9 M (+51.58 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Florence Anthony A. Jr. | 10% Owner | Buy | C | 0.00 | 1,938,562 | 0 | 1,938,562 | 0 to 1.9 M |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Chang Carmen | 10% Owner | Option Exercise | C | 0.00 | 17,099,315 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Chang Carmen | 10% Owner | Buy | P | 10.00 | 1,500,000 | 15,000,000 | 4,438,562 | 2.9 M to 4.4 M (+51.05 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Chang Carmen | 10% Owner | Buy | P | 10.00 | 1,000,000 | 10,000,000 | 2,938,562 | 1.9 M to 2.9 M (+51.58 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Chang Carmen | 10% Owner | Buy | C | 0.00 | 1,938,562 | 0 | 1,938,562 | 0 to 1.9 M |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Behbahani Ali | 10% Owner | Option Exercise | C | 0.00 | 17,099,315 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Behbahani Ali | 10% Owner | Buy | P | 10.00 | 1,500,000 | 15,000,000 | 4,438,562 | 2.9 M to 4.4 M (+51.05 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Behbahani Ali | 10% Owner | Buy | P | 10.00 | 1,000,000 | 10,000,000 | 2,938,562 | 1.9 M to 2.9 M (+51.58 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Behbahani Ali | 10% Owner | Buy | C | 0.00 | 1,938,562 | 0 | 1,938,562 | 0 to 1.9 M |
| May 13 2019 | TRVI | Trevi Therapeutics ... | BASKETT FOREST | 10% Owner | Option Exercise | C | 0.00 | 17,099,315 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | BASKETT FOREST | 10% Owner | Buy | P | 10.00 | 1,500,000 | 15,000,000 | 4,438,562 | 2.9 M to 4.4 M (+51.05 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | BASKETT FOREST | 10% Owner | Buy | P | 10.00 | 1,000,000 | 10,000,000 | 2,938,562 | 1.9 M to 2.9 M (+51.58 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | BASKETT FOREST | 10% Owner | Buy | C | 0.00 | 1,938,562 | 0 | 1,938,562 | 0 to 1.9 M |
| May 13 2019 | TRVI | Trevi Therapeutics ... | BARRIS PETER J | 10% Owner | Option Exercise | C | 0.00 | 17,099,315 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | BARRIS PETER J | 10% Owner | Buy | P | 10.00 | 1,500,000 | 15,000,000 | 4,438,562 | 2.9 M to 4.4 M (+51.05 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | BARRIS PETER J | 10% Owner | Buy | P | 10.00 | 1,000,000 | 10,000,000 | 2,938,562 | 1.9 M to 2.9 M (+51.58 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | BARRIS PETER J | 10% Owner | Buy | C | 0.00 | 1,938,562 | 0 | 1,938,562 | 0 to 1.9 M |
| May 13 2019 | TRVI | Trevi Therapeutics ... | New Enterprise Associates 16, ... | 10% Owner | Option Exercise | C | 0.00 | 17,099,315 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | New Enterprise Associates 16, ... | 10% Owner | Buy | P | 10.00 | 1,500,000 | 15,000,000 | 4,438,562 | 2.9 M to 4.4 M (+51.05 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | New Enterprise Associates 16, ... | 10% Owner | Buy | P | 10.00 | 1,000,000 | 10,000,000 | 2,938,562 | 1.9 M to 2.9 M (+51.58 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | New Enterprise Associates 16, ... | 10% Owner | Buy | C | 0.00 | 1,938,562 | 0 | 1,938,562 | 0 to 1.9 M |
| May 13 2019 | TRVI | Trevi Therapeutics ... | DRAKE PETER F | 10% Owner | Option Exercise | C | 0.00 | 376,023 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | DRAKE PETER F | 10% Owner | Option Exercise | C | 0.00 | 133,153 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | DRAKE PETER F | 10% Owner | Buy | C | 0.00 | 62,540 | 0 | 62,540 | 0 to 62.5 K |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Meeker David P | Director | Option Exercise | C | 0.00 | 478,951 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Meeker David P | Director | Option Exercise | C | 0.00 | 869,565 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Meeker David P | Director | Option Exercise | C | 0.00 | 95,712 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Meeker David P | Director | Option Exercise | C | 0.00 | 192,000 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Meeker David P | Director | Option Exercise | C | 0.00 | 924,880 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Meeker David P | Director | Buy | P | 10.00 | 11,250 | 112,500 | 352,489 | 341.2 K to 352.5 K (+3.30 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Meeker David P | Director | Buy | C | 0.00 | 13,271 | 0 | 341,239 | 328 K to 341.2 K (+4.05 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Meeker David P | Director | Buy | C | 0.00 | 27,432 | 0 | 327,968 | 300.5 K to 328 K (+9.13 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Meeker David P | Director | Buy | C | 0.00 | 300,536 | 0 | 300,536 | 0 to 300.5 K |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Omega Fund V, L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,136,986 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Omega Fund V, L.P. | 10% Owner | Buy | P | 10.00 | 481,000 | 4,810,000 | 1,063,408 | 582.4 K to 1.1 M (+82.59 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Omega Fund V, L.P. | 10% Owner | Buy | C | 0.00 | 582,408 | 0 | 582,408 | 0 to 582.4 K |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Mellon Family Investment Co V | 10% Owner | Option Exercise | C | 0.00 | 1,908,450 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Mellon Family Investment Co V | 10% Owner | Buy | P | 10.00 | 100,000 | 1,000,000 | 347,156 | 247.2 K to 347.2 K (+40.46 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Mellon Family Investment Co V | 10% Owner | Buy | J | 0.00 | 24,340 | 0 | 247,156 | 222.8 K to 247.2 K (+10.92 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Mellon Family Investment Co V | 10% Owner | Buy | C | 0.00 | 222,816 | 0 | 222,816 | 0 to 222.8 K |
| May 13 2019 | TRVI | Trevi Therapeutics ... | OSHEA WILLIAM J | 10% Owner | Option Exercise | C | 0.00 | 478,951 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | OSHEA WILLIAM J | 10% Owner | Option Exercise | C | 0.00 | 307,607 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | OSHEA WILLIAM J | 10% Owner | Buy | C | 0.00 | 99,046 | 0 | 114,080 | 15 K to 114.1 K (+658.81 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Heffernan Michael Thomas | Director | Option Exercise | C | 0.00 | 34,247 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Heffernan Michael Thomas | Director | Buy | P | 10.00 | 2,500 | 25,000 | 6,351 | 3.9 K to 6.4 K (+64.92 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Heffernan Michael Thomas | Director | Buy | C | 0.00 | 3,851 | 0 | 3,851 | 0 to 3.9 K |
| May 13 2019 | TRVI | Trevi Therapeutics ... | GOOD JENNIFER L | See Remarks | Option Exercise | C | 0.00 | 23,947 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | GOOD JENNIFER L | See Remarks | Option Exercise | C | 0.00 | 109,015 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | GOOD JENNIFER L | See Remarks | Buy | P | 10.00 | 11,250 | 112,500 | 206,204 | 195 K to 206.2 K (+5.77 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | GOOD JENNIFER L | See Remarks | Buy | C | 0.00 | 18,348 | 0 | 194,954 | 176.6 K to 195 K (+10.39 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Aperture Venture Partners IV, ... | 10% Owner | Option Exercise | C | 0.00 | 2,054,795 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Aperture Venture Partners IV, ... | 10% Owner | Buy | P | 10.00 | 112,000 | 1,120,000 | 344,963 | 233 K to 345 K (+48.08 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Aperture Venture Partners IV, ... | 10% Owner | Buy | C | 0.00 | 232,963 | 0 | 232,963 | 0 to 233 K |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Agger Mette Kirstine | Director | Option Exercise | C | 0.00 | 6,849,315 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Agger Mette Kirstine | Director | Buy | P | 10.00 | 375,000 | 3,750,000 | 1,151,544 | 776.5 K to 1.2 M (+48.29 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Agger Mette Kirstine | Director | Buy | C | 0.00 | 776,544 | 0 | 776,544 | 0 to 776.5 K |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Richard King Mellon Foundation | 10% Owner | Option Exercise | C | 0.00 | 1,908,450 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Richard King Mellon Foundation | 10% Owner | Buy | P | 10.00 | 100,000 | 1,000,000 | 347,157 | 247.2 K to 347.2 K (+40.46 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Richard King Mellon Foundation | 10% Owner | Buy | J | 0.00 | 24,341 | 0 | 247,157 | 222.8 K to 247.2 K (+10.92 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Richard King Mellon Foundation | 10% Owner | Buy | C | 0.00 | 222,816 | 0 | 222,816 | 0 to 222.8 K |
| May 13 2019 | TRVI | Trevi Therapeutics ... | VANLENT ANNE | Director | Option Exercise | C | 0.00 | 47,807 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | VANLENT ANNE | Director | Option Exercise | C | 0.00 | 107,977 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | VANLENT ANNE | Director | Buy | P | 10.00 | 5,000 | 50,000 | 25,983 | 21 K to 26 K (+23.83 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | VANLENT ANNE | Director | Buy | C | 0.00 | 20,983 | 0 | 20,983 | 0 to 21 K |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Lundbeckfond Invest A/S | 10% Owner | Option Exercise | C | 0.00 | 6,849,315 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Lundbeckfond Invest A/S | 10% Owner | Buy | P | 10.00 | 375,000 | 3,750,000 | 1,151,544 | 776.5 K to 1.2 M (+48.29 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Lundbeckfond Invest A/S | 10% Owner | Buy | C | 0.00 | 776,544 | 0 | 776,544 | 0 to 776.5 K |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Drake Debra A | 10% Owner | Option Exercise | C | 0.00 | 376,023 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Drake Debra A | 10% Owner | Option Exercise | C | 0.00 | 75,000 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Drake Debra A | 10% Owner | Option Exercise | C | 0.00 | 58,153 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Drake Debra A | 10% Owner | Buy | C | 0.00 | 10,399 | 0 | 10,399 | 0 to 10.4 K |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Drake Debra A | 10% Owner | Buy | C | 0.00 | 52,141 | 0 | 52,141 | 0 to 52.1 K |
| May 13 2019 | TRVI | Trevi Therapeutics ... | SCIASCIA THOMAS | Chief Medical Offic ... | Option Exercise | C | 0.00 | 13,410 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | SCIASCIA THOMAS | Chief Medical Offic ... | Option Exercise | C | 0.00 | 109,015 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | SCIASCIA THOMAS | Chief Medical Offic ... | Buy | C | 0.00 | 17,118 | 0 | 193,724 | 176.6 K to 193.7 K (+9.69 %) |